The Effect of Preoperative Culture Timing on Postoperative Outcomes of Retrograde Intrarenal Surgery
Launched by NAMIK KEMAL UNIVERSITY · Dec 4, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the timing of urine culture tests before retrograde intrarenal surgery (a procedure to remove kidney stones) affects the risk of complications after surgery, particularly infections. The goal is to find out the best time to take these urine tests to ensure they are still accurate and that the urine is clear of infection when patients go into surgery. Researchers want to compare urine cultures taken two weeks before the surgery with those taken as close to the surgery date as possible.
To participate in this study, patients need to be over 18 years old and must have had a urine culture taken two weeks before their surgery that showed no signs of infection. The trial is currently looking for participants, and it’s open to all genders. If you decide to join, you can expect to contribute to important research that could help improve surgical outcomes for future patients. It's important to know that certain individuals, such as those with specific kidney conditions or infections, may not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age
- • Patients who had a urine culture taken 2 weeks before the operation and reported as sterile
- Exclusion Criteria:
- • Patients under 18 years of age
- • Patients without sufficient data
- • Patients with a urine culture more than 2 weeks before retrograde intrarenal -surgery
- • Patients with a positive urine culture before retrograde intrarenal surgery
- • Patients with renal anatomic anomalies
- • Patients with a solitary (single) kidney
About Namik Kemal University
Namik Kemal University is a leading academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing patient care and developing new therapeutic approaches. Leveraging its state-of-the-art facilities and a team of experienced researchers, Namik Kemal University fosters collaborative partnerships that drive scientific discovery and contribute to the body of knowledge in clinical medicine. Through its rigorous research programs, the university aims to improve health outcomes and address pressing medical challenges, making a significant impact on both local and global health communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tekirdağ, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported